2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Tsikas D et al. | Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine. | 2000 | J Chromatogr A | pmid:10941682 |
Arnaud J et al. | Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites. | 2007 | J Am Coll Nutr | pmid:17914127 |
Martineau A et al. | Defective synthesis of vasodilator prostaglandins in the spontaneously hypertensive rat. | 1984 Mar-Apr | Hypertension | pmid:6373595 |
Falardeau P and Martineau A | In vivo production of prostaglandin I2 in Dahl salt-sensitive and salt-resistant rats. | 1983 Sep-Oct | Hypertension | pmid:6352480 |
Minuz P et al. | Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. | 1988 | Hypertension | pmid:3290103 |
Guarner F et al. | Increased synthesis of systemic prostacyclin in cirrhotic patients. | 1986 | Gastroenterology | pmid:3510938 |
Guarner C et al. | Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. | 1992 | Gastroenterology | pmid:1727763 |
Watson ML et al. | Systemic synthesis of prostaglandin I2 following sustained infusion of angiotensin II in conscious dogs. | 1986 | Eur. J. Pharmacol. | pmid:3530786 |
Greer IA et al. | Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation. | 1990 May-Jun | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:1970789 |
Vesterqvist O and Gréen K | Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man. | 1989 | Eur. J. Clin. Pharmacol. | pmid:2515064 |
Vesterqvist O | Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS. | 1986 | Eur. J. Clin. Pharmacol. | pmid:3519239 |
Larsson PT et al. | Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation. | 1992 | Eur. J. Clin. Pharmacol. | pmid:1387607 |
Edlund A et al. | Acipimox stimulates skin blood flow by a cyclo-oxygenase-dependent mechanism. | 1990 | Eur. J. Clin. Pharmacol. | pmid:2125938 |
Lahoz C et al. | Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. | 1997 | Eur. J. Clin. Invest. | pmid:9352251 |
Ross S et al. | Association of cyclooxygenase-2 genetic variant with cardiovascular disease. | 2014 | Eur. Heart J. | pmid:24796340 |
Closa D et al. | Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. | 1993 | Dig. Dis. Sci. | pmid:7678383 |
Koivisto VA et al. | Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. | 1989 | Diabetes Care | pmid:2507264 |
Rautanen M et al. | Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. | 1997 | Crit. Care Med. | pmid:9233750 |
Watson ML et al. | Prostaglandins and kallikrein during volume expansion in normal man. | 1984 | Contrib Nephrol | pmid:6570094 |
Wennmalm A et al. | Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. | 1990 | Clin. Sci. | pmid:2176952 |